A Clinical trail on kushtathy chooranam in the management of Thandagavatham (lumbar spondylosis) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, Palayamkottai

A Prospective open labelled single arm non randomized single centric phase II clinical trial on kushtathy chooranam in the management of Thandagavatham (lumbar spondylosis) - KTC

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087766

Enrollment

Registered

2025-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Kushtathy chooranam: Dosage:2 gs twice a day orally for 48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.pain and stiffness in the lumbar region 2.patients presenting with or without radiating pain to lower limb. 3.Difficulty in range of motion. 4.Patients who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Age less than 30 years and more than 65 years 2.Osteoarthritis of hip 3.Patient undergone spinal surgery 4.TB-spine 5.SLE 6.SLR test 7.Infection 8.Rheumatoid arthritis 9.Fracture of spine 10.Chronic renal and liver disease Patients 11.Pregnancy

Design outcomes

Primary

Measure	Time frame
To determine the clinical effectiveness of kushtathy chooranam in the management of Thandagavatham (Lumbar spondylosis)Timepoint: 40 days	—

Secondary

Measure	Time frame
1.To collect various Siddha literatures and modern journals for literature review on THANDAGAVATHAM 2.To study other cofactors related to disease like age, sex, dietary habits, family history, and socioeconomic status. 3.To perform physicochemical, phytochemical, bio chemical analysis of kushtathy chooranam. 4.To evaluate safety profile for acute and sub-acute toxicity of kUSHTATHY chooranam. 5.To evaluate pharmacological activities of KUSHTATHY CHOORANAM. 6.To evaluate DHEGI of Thandagavatham patients. 7.To study about the prevalence of THANDAGAVATHAM in relation with diet and lifestyle. 8.To evaluate Siddha parameters (including Envagaithervu, Neerkuri-Neikuri) in THANDAGAVATHAM during trial period. 9.To evaluate modern parametric changes in THANDAGAVATHAM. 10.To assess the quality of life of THANDAGAVATHAM patients. 11.To document Bio statistical analysis. Timepoint: 6 months	—

Measure

Time frame

1.To collect various Siddha literatures and modern journals for literature review on THANDAGAVATHAM 2.To study other cofactors related to disease like age, sex, dietary habits, family history, and socioeconomic status. 3.To perform physicochemical, phytochemical, bio chemical analysis of kushtathy chooranam. 4.To evaluate safety profile for acute and sub-acute toxicity of kUSHTATHY chooranam. 5.To evaluate pharmacological activities of KUSHTATHY CHOORANAM. 6.To evaluate DHEGI of Thandagavatham patients. 7.To study about the prevalence of THANDAGAVATHAM in relation with diet and lifestyle. 8.To evaluate Siddha parameters (including Envagaithervu, Neerkuri-Neikuri) in THANDAGAVATHAM during trial period. 9.To evaluate modern parametric changes in THANDAGAVATHAM. 10.To assess the quality of life of THANDAGAVATHAM patients. 11.To document Bio statistical analysis. Timepoint: 6 months

—

Countries

India

Contacts

Public ContactDrGSubash chandran

GOVERNMENT SIDDHA MEDICAL COLLEGE, PALAYAMKOTTAI

Siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026